Alpha-1-antitrypsin (A1AT) deficiency (also known as alpha-1) is the major known genetic risk factor for COPD1
undiagnosed
Alpha-1-antitrypsin (A1AT) deficiency (also known as alpha-1) is the major known genetic risk factor for COPD1
Because alpha-1 is the major known genetic risk factor for COPD, all COPD patients should be tested regardless of smoking history1,3
The management of alpha-1 includes both nonpharmacologic and pharmacologic components3,5
Alpha-1-antitrypsin (A1AT) deficiency (also known as alpha-1) is the major known genetic risk factor for COPD1
Because alpha-1 is the major known genetic risk factor for COPD, all COPD patients should be tested regardless of smoking history1,3
The management of alpha-1 includes both nonpharmacologic and pharmacologic components3,5
Alpha-1-antitrypsin (A1AT) deficiency (also known as alpha-1) is the major known genetic risk factor for COPD1
Because alpha-1 is the major known genetic risk factor for COPD, all COPD patients should be tested regardless of smoking history1,3
The management of alpha-1 includes both nonpharmacologic and pharmacologic components3,5
References
This site is intended only for healthcare professionals. The information herein provided is educational and should not be treated or viewed as promotional material